Introduction
Model Details
Phenotypic Evaluation
Applications
Study Examples
Introduction
Candida infection, or candidiasis, is caused by pathogenic Candida species, with Candida albicans
being a major cause of mucosal and invasive fungal disease. Clinical manifestations range from oral and genital
mucosal infections to candidemia and disseminated candidiasis. Invasive disease is particularly important in
critically ill and immunocompromised patients, including individuals receiving intensive medical treatment,
undergoing transplantation, or exposed to prolonged antimicrobial or immunosuppressive therapy. Once
Candida enters the bloodstream, it can disseminate to multiple organs and cause life-threatening systemic
infection. A major feature of C. albicans pathogenicity is its ability to switch between yeast and
filamentous hyphal forms, which contributes to tissue invasion and virulence.
Current treatment relies primarily on azoles, echinocandins, and amphotericin B, but antifungal resistance,
recurrent infection, and limited therapeutic options remain important challenges. Zebrafish provide a complementary
vertebrate system for investigating Candida pathogenesis and host defense. Published models have reproduced
dose-dependent mortality, fungal dissemination, yeast-to-hypha transition, and interactions with macrophages and
neutrophils. Transparent larvae further enable longitudinal imaging of fungal growth and immune-cell behavior,
supporting mechanistic studies and in vivo antifungal screening.
Why Zebrafish?
- Live Infection Imaging: Transparent larvae enable direct visualization of fungal growth and
immune-cell interactions.
- Innate Immunity: Macrophage and neutrophil responses can be monitored in vivo.
- Fungal Morphogenesis: Yeast-to-hypha transition can be followed during infection.
- Screening Compatible: Small size and scalable handling support in vivo antifungal
evaluation.
Available Zebrafish Disease Models
The Candida albicans infection model is the primary and most extensively characterized configuration,
complemented by mucosal, phagocyte-interaction, virulence, and treatment models:
| Model Name |
Induction Method |
Features |
| C. albicans Disseminated Infection Model |
Microinjection of C. albicans into zebrafish larvae. |
Established model for systemic fungal infection, virulence, fungal dissemination, and host defense. |
| C. albicans Mucosal Infection Model |
Direct injection of C. albicans into the swimbladder. |
Models localized mucosal infection and enables visualization of epithelial–immune–fungal interactions.
|
| Phagocyte–Candida Interaction Model |
C. albicans infection in immune-cell reporter zebrafish. |
Enables real-time analysis of macrophage and neutrophil recruitment, phagocytosis, and fungal growth. |
| Candida Virulence Model |
Infection with wild-type or genetically modified C. albicans strains. |
Supports comparative analysis of fungal virulence, morphogenesis, and immune evasion. |
| Antifungal Treatment Model |
Candida infection followed by compound or antifungal treatment. |
Enables evaluation of survival, fungal burden, fungal morphology, and host-response changes. |
Phenotypic Evaluation
Infection Progression
- Survival and mortality kinetics
- Infection-site expansion
- Fungal dissemination
- Disease progression over time
Fungal Burden & Morphology
- Fungal burden at defined time points
- Yeast-to-hypha transition
- Hyphal extension and filamentation
- Fungal localization and tissue invasion
Innate Immune Response
- Macrophage recruitment
- Neutrophil recruitment
- Phagocytosis of fungal cells
- Phagocyte–fungus interactions
- Inflammatory gene responses
Therapeutic Response
- Increased survival following treatment
- Reduced fungal burden
- Suppression of hyphal development
- Improved infection-associated pathology
- Modulation of host inflammatory responses
Tissue & Pathological Changes
- Infection-associated tissue damage
- Histopathological changes
- Hemorrhage or edema
- Local inflammatory responses
Key Applications
- Antifungal Drug Screening: Evaluate the in vivo activity of candidate compounds
against C. albicans infection.
- Candida Virulence Studies: Compare fungal strains and genetic variants to identify determinants
of pathogenicity.
- Host–Pathogen Interaction Studies: Investigate interactions between Candida cells and
macrophages, neutrophils, and other host components.
- Fungal Morphogenesis Studies: Characterize the transition from yeast to hyphal growth and its
contribution to infection progression.
- Innate Immune Mechanism Studies: Examine phagocyte recruitment, phagocytosis, oxidative
defense, and fungal immune evasion.
Study Examples
A zebrafish swimbladder model for mucosal candidiasis. The researchers developed a localized mucosal candidiasis
model by directly introducing C. albicans into the swimbladder of juvenile zebrafish. This approach
established a defined mucosal infection site where epithelial barriers, fungal growth, and innate immune responses
could be examined in vivo.
Fig. 1. Swimbladder injection establishes a localized
Candida infection for real-time analysis of mucosal host defense (Gratacap RL, Bergeron AC,
et al., 2014).
Zebrafish Candida Infection Models
Establish and evaluate zebrafish models of Candida infection for antifungal efficacy studies, fungal
virulence research, and host–pathogen interaction studies. Model configurations can be tailored to systemic or
localized infection and evaluated using survival, fungal burden, morphogenesis, immune-cell responses, and
treatment-associated phenotypes.
Reference
- Gratacap RL, Bergeron AC, et al. Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder
Injection. Journal of Visualized Experiments 2014(93), e52182.
For research use only. Not intended for any clinical use.